|
145
|
Safety Signal of Levofloxacin and the Risk of Dry mouth
|
|
Signal
|
|
|
144
|
Safety Signal of Ibuprofen and the Risk of Renal tubular acidosis
|
|
Signal
|
|
|
143
|
Safety Signal of Sitagliptin and the Risk of Fatigue
|
|
Signal
|
|
|
142
|
Safety Signal of Lactulose and the Risk of Pruritus
|
|
Signal
|
|
|
141
|
Safety Signal of Folic acid and the Risk of Constipation
|
|
Signal
|
|
|
140
|
Safety Signal of Zoster Vaccine and the Risk of Pemphigoid
|
|
Signal
|
|
|
139
|
Safety Signal of Zoster Vaccine and the Risk of Erythema multiforme
|
|
Signal
|
|
|
138
|
Safety Signal of Zoster Vaccine and the Risk of Rash Pustular
|
|
Signal
|
|
|
137
|
Safety Signal of Atezolizumab and the Risk of Sclerosing Cholangitis
|
|
Signal
|
|
|
136
|
Safety Signal of Dabrafenib and the Risk of Disseminated Intravascular Coagulopathy (DIC)
|
|
Signal
|
|
